vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Shoals Technologies Group, Inc. (SHLS). Click either name above to swap in a different company.

Shoals Technologies Group, Inc. is the larger business by last-quarter revenue ($148.3M vs $89.1M, roughly 1.7× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs 5.5%, a 2.0% gap on every dollar of revenue. On growth, Shoals Technologies Group, Inc. posted the faster year-over-year revenue change (38.6% vs 33.3%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $-11.3M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 27.8%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.

HROW vs SHLS — Head-to-Head

Bigger by revenue
SHLS
SHLS
1.7× larger
SHLS
$148.3M
$89.1M
HROW
Growing faster (revenue YoY)
SHLS
SHLS
+5.3% gap
SHLS
38.6%
33.3%
HROW
Higher net margin
HROW
HROW
2.0% more per $
HROW
7.4%
5.5%
SHLS
More free cash flow
HROW
HROW
$19.3M more FCF
HROW
$8.1M
$-11.3M
SHLS
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
27.8%
SHLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
SHLS
SHLS
Revenue
$89.1M
$148.3M
Net Profit
$6.6M
$8.1M
Gross Margin
79.3%
31.6%
Operating Margin
17.5%
11.7%
Net Margin
7.4%
5.5%
Revenue YoY
33.3%
38.6%
Net Profit YoY
-2.2%
3.9%
EPS (diluted)
$0.20
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
SHLS
SHLS
Q4 25
$89.1M
$148.3M
Q3 25
$71.6M
$135.8M
Q2 25
$63.7M
$110.8M
Q1 25
$47.8M
$80.4M
Q4 24
$66.8M
$107.0M
Q3 24
$49.3M
$102.2M
Q2 24
$48.9M
$99.2M
Q1 24
$34.6M
$90.8M
Net Profit
HROW
HROW
SHLS
SHLS
Q4 25
$6.6M
$8.1M
Q3 25
$1.0M
$11.9M
Q2 25
$5.0M
$13.9M
Q1 25
$-17.8M
$-282.0K
Q4 24
$6.8M
$7.8M
Q3 24
$-4.2M
$-267.0K
Q2 24
$-6.5M
$11.8M
Q1 24
$-13.6M
$4.8M
Gross Margin
HROW
HROW
SHLS
SHLS
Q4 25
79.3%
31.6%
Q3 25
75.3%
37.0%
Q2 25
74.5%
37.2%
Q1 25
67.5%
35.0%
Q4 24
78.8%
37.6%
Q3 24
75.6%
24.8%
Q2 24
74.4%
40.3%
Q1 24
69.5%
40.2%
Operating Margin
HROW
HROW
SHLS
SHLS
Q4 25
17.5%
11.7%
Q3 25
20.6%
13.7%
Q2 25
17.9%
14.4%
Q1 25
-23.5%
5.4%
Q4 24
19.3%
15.4%
Q3 24
2.7%
4.4%
Q2 24
3.1%
18.7%
Q1 24
-20.0%
12.8%
Net Margin
HROW
HROW
SHLS
SHLS
Q4 25
7.4%
5.5%
Q3 25
1.4%
8.7%
Q2 25
7.8%
12.5%
Q1 25
-37.2%
-0.4%
Q4 24
10.1%
7.3%
Q3 24
-8.6%
-0.3%
Q2 24
-13.2%
11.9%
Q1 24
-39.2%
5.3%
EPS (diluted)
HROW
HROW
SHLS
SHLS
Q4 25
$0.20
$0.05
Q3 25
$0.03
$0.07
Q2 25
$0.13
$0.08
Q1 25
$-0.50
$0.00
Q4 24
$0.19
$0.04
Q3 24
$-0.12
$0.00
Q2 24
$-0.18
$0.07
Q1 24
$-0.38
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
SHLS
SHLS
Cash + ST InvestmentsLiquidity on hand
$72.9M
$7.3M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$600.0M
Total Assets
$399.5M
$904.1M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
SHLS
SHLS
Q4 25
$72.9M
$7.3M
Q3 25
$74.3M
$8.6M
Q2 25
$53.0M
$4.7M
Q1 25
$66.7M
$35.6M
Q4 24
$47.2M
$23.5M
Q3 24
$72.6M
$11.1M
Q2 24
$71.0M
$3.2M
Q1 24
$76.0M
$15.2M
Total Debt
HROW
HROW
SHLS
SHLS
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
$141.8M
Q4 24
$262.7M
$141.8M
Q3 24
$230.7M
$141.8M
Q2 24
$236.3M
$146.8M
Q1 24
$243.4M
$168.8M
Stockholders' Equity
HROW
HROW
SHLS
SHLS
Q4 25
$52.4M
$600.0M
Q3 25
$47.0M
$589.6M
Q2 25
$49.7M
$575.4M
Q1 25
$56.5M
$558.9M
Q4 24
$69.7M
$556.8M
Q3 24
$58.0M
$545.2M
Q2 24
$58.5M
$544.6M
Q1 24
$60.6M
$554.0M
Total Assets
HROW
HROW
SHLS
SHLS
Q4 25
$399.5M
$904.1M
Q3 25
$363.1M
$851.8M
Q2 25
$345.0M
$795.0M
Q1 25
$364.2M
$788.4M
Q4 24
$389.0M
$793.1M
Q3 24
$351.5M
$801.3M
Q2 24
$306.6M
$788.4M
Q1 24
$295.5M
$825.3M
Debt / Equity
HROW
HROW
SHLS
SHLS
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
0.25×
Q4 24
3.77×
0.25×
Q3 24
3.98×
0.26×
Q2 24
4.04×
0.27×
Q1 24
4.02×
0.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
SHLS
SHLS
Operating Cash FlowLast quarter
$8.4M
$-4.1M
Free Cash FlowOCF − Capex
$8.1M
$-11.3M
FCF MarginFCF / Revenue
9.1%
-7.6%
Capex IntensityCapex / Revenue
0.4%
4.8%
Cash ConversionOCF / Net Profit
1.27×
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$-16.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
SHLS
SHLS
Q4 25
$8.4M
$-4.1M
Q3 25
$16.6M
$19.4M
Q2 25
$-803.0K
$-13.8M
Q1 25
$19.7M
$15.6M
Q4 24
$-17.8M
$14.0M
Q3 24
$3.0M
$15.7M
Q2 24
$-2.7M
$37.8M
Q1 24
$-4.6M
$12.9M
Free Cash Flow
HROW
HROW
SHLS
SHLS
Q4 25
$8.1M
$-11.3M
Q3 25
$16.4M
$9.0M
Q2 25
$-969.0K
$-26.0M
Q1 25
$19.5M
$12.3M
Q4 24
$-18.3M
$12.5M
Q3 24
$2.3M
$13.3M
Q2 24
$-3.1M
$35.8M
Q1 24
$-4.7M
$10.4M
FCF Margin
HROW
HROW
SHLS
SHLS
Q4 25
9.1%
-7.6%
Q3 25
22.9%
6.6%
Q2 25
-1.5%
-23.5%
Q1 25
40.8%
15.4%
Q4 24
-27.4%
11.6%
Q3 24
4.8%
13.0%
Q2 24
-6.3%
36.1%
Q1 24
-13.6%
11.4%
Capex Intensity
HROW
HROW
SHLS
SHLS
Q4 25
0.4%
4.8%
Q3 25
0.3%
7.7%
Q2 25
0.3%
11.0%
Q1 25
0.4%
4.0%
Q4 24
0.8%
1.4%
Q3 24
1.2%
2.3%
Q2 24
0.7%
2.0%
Q1 24
0.3%
2.7%
Cash Conversion
HROW
HROW
SHLS
SHLS
Q4 25
1.27×
-0.50×
Q3 25
16.26×
1.63×
Q2 25
-0.16×
-1.00×
Q1 25
Q4 24
-2.62×
1.79×
Q3 24
Q2 24
3.21×
Q1 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

SHLS
SHLS

System Solutions$122.0M82%
Components$26.3M18%

Related Comparisons